Gene discovery in type 2 diabetes
Identifying and characterizing variants that influence diabetes risk, including work on CACNA1E (CaV2.3) and adrenergic-receptor biology.
Diabetes genetics research
Research by Dr. Damon Tojjar on the genetics and biology of type 2 diabetes, from gene discovery to insulin secretion and ethnic differences in risk. Published as Tojjar, D.
Research themes
Identifying and characterizing variants that influence diabetes risk, including work on CACNA1E (CaV2.3) and adrenergic-receptor biology.
How genetic and metabolic factors shape insulin response, central to diabetes pathophysiology.
A Diabetes Care meta-analysis, cited more than 800 times, on how insulin sensitivity and response vary across populations.
Translating findings into clinical decision support, evaluated in the EASY-1 randomized trial.
Publications
Principal investigator
Dr. Damon Tojjar is a physician-scientist (M.D., Ph.D. candidate) and digital health entrepreneur whose work spans leading institutions in Europe and the United States. He earned his M.D. at Lund University, whose medical school had the lowest acceptance rate in Sweden at the time of his admission, and achieved top-percentile results on the national medical board examinations. He trained as a Research Fellow in Systems Medicine at Stanford University School of Medicine under Professor Atul Butte, where he was an Anna Lindh Fellow. His doctoral research, based at the Lund University Diabetes Centre, focuses on the genetics of type 2 diabetes.
Contact
For research collaboration, data sharing, or co-authorship, reach out directly.